Design of peptide mimetics of HIV-1 gp120 for prevention and therapy of HIV disease

Journal of Peptide Research

Volumn 62, Issue 4, 2003, Pages 158-166

  Veljkovic, N ^a   Branch, Donald R ^b,e   Metlas, R ^c   Prljic, J ^a   Vlahovicek, K ^d   Pongor, S ^d   Veljkovic, V ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF TORONTO   (Canada)

^c Quay House ^*  (Serbia)

^d INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^e CANADIAN BLOOD SERVICES   (Canada)

Author keywords

Drug design; gp120; HIV 1; Peptide mimetic

Indexed keywords

ARGINYLSERYLALANYLASPARAGINYLPHENYLALANYLTHREONYLASPARTYLASPARAGINYLALANYLL YSYLTHREONYLISOLEUCYLISOLEUCYLVALYLGLUTAMINYLLEUCYLASPARAGINYLGLUTAMYLSERYLVALYL GLUTAMYLISOLEUCYLASPARAGINE; GLYCOPROTEIN GP 120; HISTIDYLSERYLASPARTYLALANYLVALYLPHENYLALANYLTHREONYLASPARTYLASPARAGINYLTYRO SYLTHREONYLARGINYLLEUCYLARGINYLLYSYLGLUTAMINYLMETHIONYLALANYLVALYLLYSYLLYSYLTYRO SYLLEUCYLASPARAGINYLSERYLISOLEUCYLLEUCYLASPARAGINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PEPTIDE; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE ANTIBODY; VIRUS GLYCOPROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ARTICLE; BIOINFORMATICS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE COURSE; DRUG DESIGN; DRUG INDICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; MOLECULAR MIMICRY; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; SIGNAL PROCESSING; TREATMENT INDICATION; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0141727804     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3011.2003.00081.x     Document Type: Article

References (38)

1. Neurath, A.R., Strick, N., Tajlor, P., Rubinstain, P. & Stevans, C.E. (1990) Search for epitope-specific antibody responses to the human immunodeficiency virus (HIV-1) envelope glycoproteins signifying resistance to disease development. AIDS Res. Hum. Retroviruses 6, 1183-1192.
2. Veljkovic, V., Metlas, R., Jevtovic, D.J. & Stringer, W. (2001) The role of passive immunization in HIV-positive patients: a case report. Chest 120, 662-666.
3. Mathiesen, T., Broliden, P.A., Rosen, J. & Wahren, B. (1989) Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides. Immunology 67, 453-459.
4. Wahren, B., Rosen, J., Sandstrom, E., Mathiesen, T., Modrow, S. & Wigzell, H. (1989) HIV-1 peptides induce a proliferative response in lymphocytes from infected persons. J. Acquir. Immune Defic. Syndr. 2, 448-456.
5. Geretti, A.M., Van Baalen, C.A., Borleffs, J.C., Van Els, C.A. & Osterhaus, A.D. (1994) Kinetics and specificities of the T helper-cell response to gp120 in the asymptomatic stage of HIV-1 infection. Scand. J. Immunol. 39, 355-362.
6. Mutch, D., Underwood, J., Geysen, M. & Rodda, S. (1994) Comprehensive T-cell epitope mapping of HIV-1env antigens reveals many areas recognized by HIV-1-seropositive and by low-risk HIV-1-seronegative individuals. J. Acquir. Immune Defic. Syndr. 7, 879-890.
7. Sitz, K.V., Ratto-Kim, S., Hodgkins, A.S., Robb, M.L. & Birx, D.L. (1999) Proliferative responses to human immunodeficiency virus type 1 (HIV-1) gp120 peptides in HIV-1-infected individuals immunized with HIV-1 rgp120 or rgp160 compared with nonimmunized and uninfected controls. J. Infect. Dis. 179, 817-824.
8. Kusk, P., Holmback, K., Lindhardt, B.O., Hilgaard, E.F. & Bugge, T.H. (1992) Mapping of two new human B-cell epitopes on HIV-1 gp120. AIDS 6, 1451-1456.
9. Lemasson, I., Housset, V., Calas, B. & Devaux, C. (1995) Antigenic analysis of HIV type1 external envelope (Env) glycoprotein C2 region: implication for the structure of env. AIDS Res. Hum. Retrovir. 11, 1177-1182.
10. Bradac, J.A. & Mathieson, B.J. (1991) An Epitope Map of Immunity to HIV-1: a Roadmap for Vaccine Development. Division of AIDS, NIAID, NIH, Bethesda.
11. Sastry, K.J. & Arlinghaus, R.B. (1991) Identification of T-cell epitopes without B-cell activity in the first and second conserved regions of the HIV env protein. AIDS 5, 699-707.
12. Veljkovic, V. & Metlas, R. (1990) Sequence similarity between HIV-1 env protein gp120 and human proteins: a new hypothesis on protective antibody production. Immunol. Lett. 26, 193-196.
13. Veljkovic, V., Metlas, R., Raspopovic, J. & Pongor, S. (1992) Spectral and sequencesimilarity between VIP and the second conserved region of HIV envelope glycoprotein gp120: possible consequences on prevention and therapy of AIDS. Biochem. Biophys. Res. Commun. 189, 705-710.
14. Veljkovic, V., Metlas, R., Vojvodic, D., Cavor, L.J., Pejinovic, N., Dujic, A., Zakhariev, S., Guarnaccia, C. & Pongor, S. (1993) Natural autoantibodies cross-react with a peptide derived from the second conserved region of HIV-1 envelope glycoprotein gp120. Biochem. Biophys. Res. Commun. 196, 1019-1024.
15. Veljkovic, V., Cosic, I., Dimitrijevic, B. & Lalovic, D. (1985) Is it possible to analyze DNA and protein sequence by the method of digital signal processing? IEEE Trans. BME. 32, 337-341.
16. Veljkovic, V. & Cosic, I. (1987) A novel method of protein analysis for prediction of biological function. Cancer Biochem. Biophys. 9, 139-148.
17. Lazovic, J. (1996) Selection of amino acid parameters for Fourier transform-based analysis of proteins. Comp. Appl. Bio. Sci. 16, 553-558.
18. Cosic, I. (1997) The Resonant Recognition Model of Macromolecular Bioreactivity: Theory & Application. Birkhauser Verlag, Berlin.
19. Veljkovic, V. & Slavic, I. (1972) Simple general-model pseudopotential. Phys. Rev. Lett. 29, 105-107.
20. Veljkovic, V. (1973) The dependence of the Fermi energy on the atomic number. Phys. Lett. 45A, 41-42.
21. Veljkovic, V. (1980) A Theoretical Approach to Preselection of Cancerogens and Chemical Carcinogenesis. Gordon & Breach, New York.
22. Lalovic, D. & Veljkovic, V. (1990) The global average DNA base composition of coding regions may be determined by the electron-ion interaction potential. BioSystems 23, 311-316.
23. Cosic, I., Nesic, D., Pavlovic, M. & Williams, R. (1986) Enhancer binding proteins predicted by informational spectrum method. Biochem. Biophys. Res. Commun. 141, 831-838.
24. Skerl, V. & Pavlovic, M. (1988) Thymopoetins and long postsynaptic neurotoxins share common information in their primary structures. FEBS Lett. 239, 1411-1416.
25. Veljkovic, V. & Metlas, R. (1988) Identification of nanopeptide from HTLV3, LAV and ARV-2 envelope gp120 determining binding to T4 cell surface protein. Cancer Biochem. Biophys. 10, 191-196.
26. Cosic, I. & Nesic, D. (1988) Prediction of 'hot spots' in SV40 enhancer and relation with experimental data. Eur. J. Biochem. 170, 247-252.
27. Cosic, I., Pavlovic, M. & Vojisavljevic, V. (1989) Prediction of 'hot spots' in interleukin-2 based on informational spectrum characteristics of growth regulating factor. Biochemie 71, 333-339.
28. Cosic, I., Vojisavljevic, V. & Pavlovic, M. (1989) The relationship of the resonant recognition model to effects of low-intensity light on cell growth. Int. J. Radiat. Biol. 56, 179-184.
29. Cosic, I. (1990) Resonant Recognition Model of Protein-Protein and Protein-DNA Interaction in Bioinstrumentation and Biosensors. Marcel Dekker, New York.
30. Cosic, I., Hodder, A., Aguilar, M. & Hearn, M. (1991) Resonant recognition model and protein topography: model studies with myoglobin, hemoglobin and lysozyme. Eur. J. Biochem. 198, 113-119.
31. Cosic, I. & Hearn, M. (1991) 'Hot spot' amino acid distribution in Ha-ras oncogene product p21: relationship to guanine binding site. J. Mol. Rec. 4, 57-62.
32. Cosic, I. (1994) Macromolecular bioactivity:is it resonant interaction between macromolecules? Theory and applications. Trans. Biomed. Eng. 12, 1101-1108.
33. Cosic, I. & Drummond, A.E., Underwood, J.R. & Hearn, M. (1994) In vitro inhibition of the actions of basic FGF by a novel 16 amino acid peptide. Mol. Cell. Biochem. 130, 1-7.
34. Veljkovic, V., Johnson, E. & Metlas, R. (1995) Analogy of HIV-1 to oncogenic viruses: possible implications for the pathogenesis of AIDS. Cancer J. 8, 308-312.
35. Cosic, I. (1995) Virtual spectroscopy for fun and profit. Biotechnology 3, 236-238.
36. Krsmanovic, B., Cosic, I., Biquard, J. & Hearn, M. (1998) Investigations into the crossreactivity of rabbit antibodies raised against nonhomologous pairs of synthetic peptides derived HIV-1 gp120 proteins. J. Peptide Res. 52, 410-418.
37. Thompson, J.D., Higgins, D.G. & Gibson, T.J. (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acid Res. 22, 4673-4681.
38. Felsenstein J. (1993) PHYLIP (Phylogeny Inference Package), version 3.5c.